Surgical Treatment of Abdominal Tumors

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 695

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgery, General Hospital of Volos, Volos, Greece
Interests: surgery; clinical trials; oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Surgery, University Hospital of Larissa, Larissa, Greece
Interests: surgery; clinical trials; colorectal; minimally invasive; laparoscopic

Special Issue Information

Dear Colleagues,

Surgical treatment is considered the gold standard approach for most abdominal tumors. Despite the introduction of various therapeutic modalities in the field of surgical oncology, surgical resection of intra-abdominal and abdominal wall malignancies allows optimal source control and enhanced oncological outcomes. Several aspects of surgical management, including operative technique and perioperative optimization, have been identified as prognostic factors for morbidity, mortality, and tumor-free survival. Subsequently, to augment postoperative outcomes, current research efforts focus on refining each individual domain of operative management of abdominal tumors.

We are pleased to invite you to this Special Issue, entitled “Surgical Treatment of Abdominal Tumors”, of Cancers. This Special Issue aims to highlight recent advancements in the surgical management of abdominal tumors while also addressing all current application issues and future research directions. 

In this Special Issue, original research studies and review articles are welcome. Research topics may include, but are not limited to, the following:

  • Surgery for intra-abdominal and abdominal wall malignancies;
  • Improving oncological efficacy;
  • Enhanced recovery after an abdominal tumor resection;
  • Adjunctive surgical techniques;
  • The role of minimally invasive approaches.

We look forward to receiving your contributions.

Dr. Konstantinos Perivoliotis
Dr. Ioannis Baloyiannis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • abdominal
  • abdominal wall
  • tumors
  • surgery
  • cancer
  • malignancy
  • oncology
  • intraperitoneal
  • extraperitoneal

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1100 KiB  
Review
The Role of Prophylactic HIPEC in High-Risk Gastric Cancer Patients: Where Do We Stand?
by Alexandros Diamantis, Athina A. Samara, Anastasios Lafioniatis, Michel B. Janho, Theodoros Floros and Konstantinos Tepetes
Cancers 2025, 17(15), 2492; https://doi.org/10.3390/cancers17152492 - 28 Jul 2025
Viewed by 264
Abstract
For patients diagnosed with a malignancy at high risk of developing peritoneal metastases, the concept of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged. The aim of the present study is to assess the role of prophylactic HIPEC in gastric cancer patients at high [...] Read more.
For patients diagnosed with a malignancy at high risk of developing peritoneal metastases, the concept of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged. The aim of the present study is to assess the role of prophylactic HIPEC in gastric cancer patients at high risk of PC, based on the currently available data in the literature. In total, 14 RCTs and 16 non-RCTs were identified and included in the present review, with 1383 patients included in the RCTs (627 of whom underwent HIPEC) and 1647 patients included in the non-RCTs (with 609 undergoing HIPEC). Prophylactic HIPEC appears to be useful and effective in treating patients with high-risk gastric cancer, improving both overall and disease-free survival. The heterogeneity of data regarding treatment protocols and complication rates suggests that further research is necessary to develop optimal therapeutic approaches and personalized treatment options; in particular, large-scale randomized control trials are needed in order to elucidate the potential benefits associated with the use of prophylactic HIPEC. Full article
(This article belongs to the Special Issue Surgical Treatment of Abdominal Tumors)
Show Figures

Figure 1

Back to TopTop